As the international community reengages visiting the United States, the Centers for Disease Control and Prevention (CDC) recently announced a few changes in its travel vaccination policy.
As of April 27, 2023, the CDC's website says if you are a non-U.S. citizen who is a nonimmigrant (not a U.S. citizen, U.S. national, lawful permanent resident, or traveling to the U.S. on an immigrant visa), you will need to show proof of being fully vaccinated against COVID-19 before you travel by air to the United States from a foreign country.
Relaxed Restrictions for Select International Visitors
Gonorrhea Risk Reduced with Oral Antibiotic
The number of sexually transmitted infections (STIs), such as chlamydia, syphilis, and gonorrhea, has recently increased. And without STI preventive vaccines available, future trends appear disappointing.
However, the U.S. National Institutes of Health (NIH) recently announced a common treatment that could reduce these unfortunate infections.
Sexually Transmitted Infections Reduced by Common Antibiotic
The number of sexually transmitted infections (STIs), such as chlamydia, syphilis, and gonorrhea, has recently increased. And without STI preventive vaccines available, future trends appear disappointing.
However, the U.S. National Institutes of Health (NIH) recently announced a common treatment that could reduce these unfortunate infections.
Sexually Transmitted Disease Vaccine Development Remain Underwhelming
The U.S. Sexually Transmitted Infections (STI) National Strategic Plan includes, but is not limited to, vaccine and treatment research focused on chlamydia, gonorrhea, and Mpox.
According to recent STI reports, additional clinical evaluations and research are needed for these diseases.
Sexually Transmitted Disease Treatment and Vaccines Remain Underwhelming
The U.S. Sexually Transmitted Infections (STI) National Strategic Plan includes, but is not limited to, vaccine and treatment research focused on chlamydia, gonorrhea, and Mpox.
According to recent STI reports, additional clinical evaluations and research are needed for these diseases.
Mortality High for Patients With Concurrent TB, COVID-19
In adjusted analysis, 31 percent of people with concurrent diseases died
New COVID-19 Drug Guards Against All Variants in Immunocompromised
Trial results could be out by September and may lead to FDA emergency use authorization
CDC Relaxes COVID-19 Vaccination Rules for Foreign Travelers
U.S. health officials say that foreigners coming to the United States will now only need one bivalent shot to enter the country
Africa's Meningitis Belt Most Fatal in Nigeria
The World Health Organization (WHO) today announced the Federal Republic of Nigeria's meningitis outbreak had caused severe concerns this year.
The WHO reported on April 27, 2023, between October 2022, and April 16, 2023, Nigeria confirmed 1,686 suspected cases of meningitis, including 124 deaths, for a case fatality ratio (CFR) of 7%.
Unfortunately, the highest proportion of reported cases is among children aged 1 to 15.
And the Jigawa state accounts for 74% of all suspected meningitis cases.
Broadly Neutralizing Antibody Could Lead to Zika Vaccines
Researchers at Seattle’s Fred Hutchinson Cancer Center recently discovered a potent antibody that appears to block mosquito-borne viruses.
The newly found antibody can block the Zika virus, as well.
Fred Hutch researcher Leslie Goo, Ph.D., MPH, is an expert in flaviviruses, a family of pathogens that include Zika, dengue, West Nile, yellow fever, and Japanese encephalitis viruses.